OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study. (PubMed, Clin Ther) - Dec 13, 2022 - P2 | "OCS-01 once daily and BID were more effective than vehicle and well tolerated in the treatment of inflammation and pain after cataract surgery."
Clinical • Journal • Cataract • Immunology • Inflammation • Ophthalmology • Pain
|